Company Name
Shanghai Haohai Medical Technology Development Co.,Ltd.
Company Introduction
Shanghai Haohai Medical Technology Development Co., Ltd. (hereinafter referred to as Haohai Vision) is the eye health business segment of Shanghai Haohai Biological Technology Co., Ltd. ,the first biopharmaceutical company in China listed on both the SSE STAR Market and the Hong Kong Stock Exchange.
Founded in 2007, Haohai Vision has 18 years of expertise across the full industry chain, from raw materials to R&D, production,and sales. Today, we rank as a globally leading producer of intraocular lenses (IOLs), holding a prominent market share in China with annual sales exceeding 1 million units. In addition, our ophthalmic viscosurgical device (OVD) has maintained the No. 1 position in the Chinese market for 18 consecutive years.
With a global perspective, we advance intelligent manufacturing in China. Supported by 7 R&D bases across 3 continents, we are committed to the efficient translation and localization of advanced technologies, enabling us to provide comprehensive eye health solutions accessible to patients worldwide throughout the full life cycle.
Haohai Vision is shaping a new future of eye health, unlocking infinite possibilities for an extraordinary visual world.
Size (number of persons)
20
Official website
Contact person
WU DIAN
Contact email
wudian@3healthcare.com
Product Name
FVR IOL
Medical Sodium Hyaluronate Gel
Trifocal IOL and Trifocal Toric IOL
Simedice®Monofocal Toric IOL
“Eyesucom®
Lubricant eye drops”
Product Introduction + Highlights
1. Patented Fourier Harmonic Diffractive Technology
Achieves nearly 100% light energy utilization at a 3.5 mm pupil diameter.
2. Five-Focus Full-Range Vision Design
Provides high-quality vision across the full visual range, from distance to near.
3. P.U.R.E. Impurity Removal Technology
Helps reduce postoperative inflammatory response by removing impurities.
4. Nanometer-Scale CNC Manufacturing Process
A polishing-free process that reduces energy loss and optical interference.
5. 360° Anti-PCO ring design
Features a 360-degree continuous ridge structure to help prevent posterior capsule opacification. A cohesive OVD characterized by high viscoelasticity, providing effective anterior chamber maintenance and surgical support. It also demonstrates excellent adhesiveness and coating ability, and can be removed easily at the end of surgery. A complete solution for cataracts and astigmatism, suitable for a broader range of cataract patients with visual needs across all distances.
The Weighted Phase Model (W.P.M.) design increases the utilization rate of light to 90%, ensuring a smooth defocus curve and high-definition vision across the full viewing range. V-Free precision filtering technology reduces visual disturbances.
The long-term effect is stable and excellent, resulting in high patient satisfaction. Designed to replace the natural lens in patients with cataracts and astigmatism, while correcting corneal astigmatism.
The 0.25D small step cylindrical diopter, combined with ultra-precision moulding technology, has less residual astigmatism and more accurate diopter；The improved C loop with large contact angle, combined with the frosted, brings outstanding rotational stability. Featuring 0.4% chitosan and 0.05% sodium hyaluronate as its key ingredients, this formula works together to create a powerful synergistic effect.
Long-lasting hydration: Positively charged chitosan bonds with negatively charged mucins on the ocular surface, while at the same time, forming complex structures with sodium hyaluronate to lock in moisture for lasting hydration.
Dual repair effects: Compared to hyaluronic acid, chitosan has a stronger ability to promote corneal epithelial repair; the two ingredients work culmunatively to provide a dual repair effects.
Natural antibacterial protection: The positively charged chitosan can bind to the negatively charged surfaces of bacteria, exerting a natural antibacterial effect.
Available in single-dose and preservative-free multi dose formulations.
Can the products be experienced on-site?
NO
Are the products certified in Thailand and Malaysia?
NO
Is the product leading in the industry?
YES
Have the products been exported to Europe, America or other countries?
YES
Demand for Exhibits
1.Understand the market access requirements for medical devices and pharmaceuticals in overseas markets.
2.Enhance brand awareness and industry standing.
3.Expand new international clients and technical collaborations.
4.Develop new distributors, agents, and partners.